"Independently Owned and Operated since 2004"

During the past decade, Sensenbrenner Primary Care conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 7 clinical trials were completed, i.e. on average, 700% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sensenbrenner Primary Care" #1 sponsor was "Mannkind Corporation" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "Esperion Therapeutics, Inc." with 1 trials sponsored, "Novartis" with 1 trials sponsored and "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sensenbrenner Primary Care" #1 collaborator was "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Sensenbrenner Primary Care" are "Cardiovascular Disease" (2 trials), "Arthritis, Rheumatoid" (1 trials), "COPD" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Diabetes Type 2" (1 trials). Many other conditions were trialed in "Sensenbrenner Primary Care" in a lesser frequency.

Most popular intervention types in "Sensenbrenner Primary Care" are "Drug" (9 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "bococizumab (PF-04950615)" (2 trials), "70% insulin aspart protamine suspension and 30% insulin aspart injection (rDNA origin)" (1 trials), "Atorvastatin 20mg" (1 trials) and "Bempedoic acid 180mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sensenbrenner Primary Care" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Sensenbrenner Primary Care". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Sensenbrenner Primary Care, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Sensenbrenner Primary Care, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".